Document Detail


Melatonin cytotoxicity in human leukemia cells: relation with its pro-oxidant effect.
MedLine Citation:
PMID:  16448397     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Melatonin has a variety of functions in human physiology and is involved in a number of pathological events including neoplastic processes. The tissue protective actions of melatonin are attributed to its antioxidant activity though, under certain conditions, melatonin might also exert oxidant effects, particularly in cancer cells. This study evaluated the effects of 10(-5) and 10(-3) m concentrations of melatonin on human leukemia cells. Moderate cytotoxic effects of melatonin at 10(-3) m concentrations were observed in CMK, Jurkat and MOLT-4 cells which was associated with significant reactive oxygen species (ROS) generation. Melatonin treatment was not associated with significant cytotoxicity in HL-60 cells, although the generation of ROS was significantly increased. K562 and Daudi cells did not appear to be effected by melatonin treatment. Cellular membrane lipid peroxidation was not influenced by melatonin with the exception of CMK cells. Cell cycle kinetics were not affected in melatonin-treated samples, again with the exception of CMK cells which showed increased apoptosis. Melatonin, therefore, induces the production of ROS that may be associated with cytotoxicity depending on the concentration of melatonin in some leukemia cells and does not appear to stimulate leukemia cell growth. These pro-oxidant actions of melatonin may assist in limiting leukemic cell growth.
Authors:
Mustafa Büyükavci; Oner Ozdemir; Steven Buck; Mark Stout; Yaddanapudi Ravindranath; Süreyya Savaşan
Related Documents :
20433757 - Non-monotonic changes in clonogenic cell survival induced by disulphonated aluminum pht...
12757857 - Spin traps: in vitro toxicity and stability of radical adducts.
4006097 - Direct observation of the "oxygen paradox" in single rat ventricular myocytes.
17644737 - Cd45ro enriches for activated, highly mutated human germinal center b cells.
7717047 - Ultrastructural classification of the endocrine cells of the large intestine of the cal...
22488057 - Heat shock and cold shock treatments affect the survival of listeria monocytogenes and ...
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Fundamental & clinical pharmacology     Volume:  20     ISSN:  0767-3981     ISO Abbreviation:  Fundam Clin Pharmacol     Publication Date:  2006 Feb 
Date Detail:
Created Date:  2006-02-01     Completed Date:  2006-07-17     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  8710411     Medline TA:  Fundam Clin Pharmacol     Country:  England    
Other Details:
Languages:  eng     Pagination:  73-9     Citation Subset:  IM    
Affiliation:
Division of Hematology/Oncology, Children's Hospital of Michigan, Barbara Ann Karmanos Cancer Institute, Wayne State University, Detroit, MI, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Apoptosis / drug effects
Cell Survival / drug effects
Dose-Response Relationship, Drug
HL-60 Cells
Humans
Jurkat Cells
Leukemia / metabolism,  pathology
Melatonin / toxicity*
Oxidants / toxicity*
Reactive Oxygen Species / metabolism*
Chemical
Reg. No./Substance:
0/Oxidants; 0/Reactive Oxygen Species; 73-31-4/Melatonin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Anti-inflammatory effect of licofelone against various inflammatory challenges.
Next Document:  Comparing reagents for efficient transfection of human primary myoblasts: FuGENE 6, Effectene and Ex...